Forte Medical joins ABHI UK Healthcare Pavilion

The Association of British HealthTech Industries (ABHI) recently launched the UK Healthcare Pavilion, a single platform to unite MedTech companies with the UK healthcare sectors, both NHS and private. Forte Medical is very happy to have joined such an august and respected portfolio of companies, providers and innovators.  Our entry features films about our technology featuring advocates, policy makers, healthcare professionals and the AHSN Network. Click here to view.

US Partnership Deal With Owen Mumford Announced

The partnership between Forte Medical and Owen Mumford USA was launched today at the OCTANe Medical Innovation Technology Forum (MTIF) at Newport Beach, CA 28-29 October 2019. 

Introducing Peezy Midstream to the USA has long been an ambition of Forte Medical. Our disruptive and innovative MedTech called for a partner with experience, knowledge and a savvy mindset. We found that partner in Atlanta-based Owen Mumford USA whose reach covers the USA and Canada and is managed by Travis Shaw.

Owen Mumford has been at the forefront of medical device innovation for over 65 years, creating solutions that improve the delivery of healthcare and home health treatments for people around the world. Their products span devices that make blood testing more comfortable to solutions that make it easier to administer life-saving medication.

Owen Mumford’s experience in medical devices began in the 1950s when founders Ivan Owen and John Mumford established the company. The company have direct sales offices and a network of distribution partners serving customers in over 60 countries, and employ over 800 people across the Americas, Europe and Asia.  

“Owen Mumford USA is delighted to partner Forte Medical in North America and Canada,” says Travis Shaw. “Our team looks forward to expanding our mutual synergies. Research indicates that Peezy Midstream can add significant clinical and cost value to healthcare providers, a true win-win for all parties.”
 
Thanks to the Greater Irvine Chamber of Commerce for making this possible.

Antibiotics and urinary tract infections

Antibiotics, better tests, UTI: Guardian publishes Forte response

A rise in persistent UTIs could be linked to antibiotic crackdown appeared in The Guardian on Saturday 5th October. As usual, no-one mentioned accurate basic specimen collection, which can lead to unwarranted specimen quality variation, failed analysis and less-than-targeted prescribing. Giovanna Forte had something to say. Click here to read her published letter.

urine infection testing

New study concludes midstream urine optimises point of care accuracy

An interesting study published in the Scandinavian Journal of Primary Health Care which concludes: “MSU samples should be used in general practice for optimal accuracy of POC tests.”

Click here for more information Sampling of urine for diagnosing urinary tract infection in general practice – First-void or mid-stream urine?

Hoelmkjaer Pernille, Bjerrum Lars, Mäkelä Marjukka, Siersma Volkert & Holm Anne (2019): Sampling of urine for diagnosing urinary tract infection in general practice – First-void or mid-stream urine?, Scandinavian Journal of Primary Health Care, DOI: 10.1080/02813432.2019.1568708
Urine specimen testing

Urine Is Liquid Gold When It Comes To Testing

Today’s Hippocratic Post features an overview on the importance of urine and the evidence supporting why our technology plays such a vital role in enabling right-first-time diagnosis and treatment.

 

Giovanna Forte What is Peezy Midstream

Maximising our MedTech Might

The benefits of working with the NIHR are clearly demonstrated through past posts and this is the latest to come out of Forte Medical NIHR partnership…

“CEO of Forte Medical, describes how the NIHR supported her company to generate clinical evidence for the Peezy™ Mid-Stream Urine device – an easier, cleaner and more reliable urine sample collection. Watch the full video here: https://lnkd.in/gY-6MMx

Or get in touch: supportmystudy@nihr.ac.uk

Forte Medical Review

A Year In Review – 2018

  • New evidence showing a 70% reduction in false positive dipped specimens
  • Extended uptake by the NHS
  • Investment including a JV to create a Smart Peezy
  • Sheena Byrom joining our Advisory Panel
  • Being recognised in the Sunday Times 2018 Maserati 100 list that celebrate British entrepreneurship

These have been a few of our highlights for 2018 – to read more, please click here

Misdiagnosis of urine samples

Mr Ased Ali – Making Urine Samples Trustworthy

The latest issue of Urology News features an interesting and important conversation with Urological Consultant Mr Ased Ali about the importance of urine in diagnosis and subsequent treatment of UTIs.  He refers to the patient-led initiative – the MUST Campaign – that is demanding Government introduce a protocol for the collection of urine specimens.

The article supports the work being undertaken – the petition can be signed here – and the article itself is on page 35 of the November/December issue.

Clinical research using the Peezy Midstream shows a 70% reduction in false positive dipped urines and mixed growth/contamination reduced from the national average of 22.5% to just 2%.  Our contribution to making urine samples trustworthy

Peezy Usability Study Forte Medical

Peezy Midstream Case Study at NHS NIHR Conference 2018

Back in March of this year, the NHS National Institute for Health Research contacted Forte Medical, asking for a case study demonstrating how their research has assisted the launch of Peezy Midstream.

A few months earlier the NIHR in conjunction with the West Midlands AHSN conducted a valuable Usability Study on our diagnostic device. Results were excellent and have assisted us with adoption training and reassurance to HCPs and patients alike that using Peezy Midstream is far, far easier than trying to deliver this elusive urine specimen any other way …

The case study presented by Giovanna Forte on 10th October 2018 was very well received and has already led to enquiries from Primary Care clinicians who can see the benefit of right-first-time diagnoses for UTI and other common conditions that can take up so much GP time when left untreated.

2018 NIHR Peezy Presentation

NIHR_PeezyMidstream-Case-Study

urine sample testing

“If you come down with a UTI, seek treatment and get your urine tested.”

This is the latest recommendation following publication of a Californian study about the rise of antibiotic-resistant bacteria.   But right-first-time diagnosis and treatment is only possible if the urine sample is collected correctly in the first place.

In the UK, nearly 1 in 3 women will have a UTI by the time they are 24 and around 1 in 30 boys by the age of 16.   Additionally – according to the Unplanned Admissions Committee  the NHS spent £434 million in 2013/14 on treating 184,000 patients in unplanned admissions associated with a UTI.